These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 27753464)

  • 41. New Multidrug Efflux Inhibitors for Gram-Negative Bacteria.
    Marshall RL; Lloyd GS; Lawler AJ; Element SJ; Kaur J; Ciusa ML; Ricci V; Tschumi A; Kühne H; Alderwick LJ; Piddock LJV
    mBio; 2020 Jul; 11(4):. PubMed ID: 32665275
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Development and application of a cellular, gain-of-signal, bioluminescent reporter screen for inhibitors of type II secretion in Pseudomonas aeruginosa and Burkholderia pseudomallei.
    Moir DT; Di M; Wong E; Moore RA; Schweizer HP; Woods DE; Bowlin TL
    J Biomol Screen; 2011 Aug; 16(7):694-705. PubMed ID: 21602485
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Syd, a SecY-interacting protein, excludes SecA from the SecYE complex with an altered SecY24 subunit.
    Matsuo E; Mori H; Shimoike T; Ito K
    J Biol Chem; 1998 Jul; 273(30):18835-40. PubMed ID: 9668058
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Resistance of Gram-Negative Bacteria to Current Antibacterial Agents and Approaches to Resolve It.
    Breijyeh Z; Jubeh B; Karaman R
    Molecules; 2020 Mar; 25(6):. PubMed ID: 32187986
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bacterial Peptide deformylase inhibitors: a new class of antibacterial agents.
    Jain R; Chen D; White RJ; Patel DV; Yuan Z
    Curr Med Chem; 2005; 12(14):1607-21. PubMed ID: 16022661
    [TBL] [Abstract][Full Text] [Related]  

  • 46. New Broad-Spectrum Antibiotics Containing a Pyrrolobenzodiazepine Ring with Activity against Multidrug-Resistant Gram-Negative Bacteria.
    Picconi P; Hind CK; Nahar KS; Jamshidi S; Di Maggio L; Saeed N; Evans B; Solomons J; Wand ME; Sutton JM; Rahman KM
    J Med Chem; 2020 Jul; 63(13):6941-6958. PubMed ID: 32515951
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mechanistic Understanding Enables the Rational Design of Salicylanilide Combination Therapies for Gram-Negative Infections.
    Copp JN; Pletzer D; Brown AS; Van der Heijden J; Miton CM; Edgar RJ; Rich MH; Little RF; Williams EM; Hancock REW; Tokuriki N; Ackerley DF
    mBio; 2020 Sep; 11(5):. PubMed ID: 32934086
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The development of efflux pump inhibitors to treat Gram-negative infections.
    Blanco P; Sanz-García F; Hernando-Amado S; Martínez JL; Alcalde-Rico M
    Expert Opin Drug Discov; 2018 Oct; 13(10):919-931. PubMed ID: 30198793
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recent Process in the Inhibitors of UDP-3-O-(R-3-hydroxyacyl)-Nacetylglucosamine Deacetylase (LpxC) Against Gram-Negative Bacteria.
    Liu F; Ma S
    Mini Rev Med Chem; 2018; 18(4):310-323. PubMed ID: 27739357
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bismuth Drugs Reverse Tet(X)-Conferred Tigecycline Resistance in Gram-Negative Bacteria.
    Deng T; Jia Y; Tong Z; Shi J; Wang Z; Liu Y
    Microbiol Spectr; 2022 Feb; 10(1):e0157821. PubMed ID: 35138168
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interaction of SecB with soluble SecA.
    den Blaauwen T; Terpetschnig E; Lakowicz JR; Driessen AJ
    FEBS Lett; 1997 Oct; 416(1):35-8. PubMed ID: 9369228
    [TBL] [Abstract][Full Text] [Related]  

  • 52. GroEL/ES inhibitors as potential antibiotics.
    Abdeen S; Salim N; Mammadova N; Summers CM; Frankson R; Ambrose AJ; Anderson GG; Schultz PG; Horwich AL; Chapman E; Johnson SM
    Bioorg Med Chem Lett; 2016 Jul; 26(13):3127-3134. PubMed ID: 27184767
    [TBL] [Abstract][Full Text] [Related]  

  • 53. SecA: the ubiquitous component of preprotein translocase in prokaryotes.
    Schmidt MG; Kiser KB
    Microbes Infect; 1999 Oct; 1(12):993-1004. PubMed ID: 10617931
    [TBL] [Abstract][Full Text] [Related]  

  • 54. SecA mediates cotranslational targeting and translocation of an inner membrane protein.
    Wang S; Yang CI; Shan SO
    J Cell Biol; 2017 Nov; 216(11):3639-3653. PubMed ID: 28928132
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Discovery of Macrolide Antibiotics Effective against Multi-Drug Resistant Gram-Negative Pathogens.
    Myers AG; Clark RB
    Acc Chem Res; 2021 Apr; 54(7):1635-1645. PubMed ID: 33691070
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dissecting structures and functions of SecA-only protein-conducting channels: ATPase, pore structure, ion channel activity, protein translocation, and interaction with SecYEG/SecDF•YajC.
    Hsieh YH; Huang YJ; Zhang H; Liu Q; Lu Y; Yang H; Houghton J; Jiang C; Sui SF; Tai PC
    PLoS One; 2017; 12(6):e0178307. PubMed ID: 28575061
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of the magnesium-binding domain of the high-affinity ATP-binding site of the Bacillus subtilis and Escherichia coli SecA protein.
    van der Wolk JP; Klose M; de Wit JG; den Blaauwen T; Freudl R; Driessen AJ
    J Biol Chem; 1995 Aug; 270(32):18975-82. PubMed ID: 7642557
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lipids Activate SecA for High Affinity Binding to the SecYEG Complex.
    Koch S; de Wit JG; Vos I; Birkner JP; Gordiichuk P; Herrmann A; van Oijen AM; Driessen AJ
    J Biol Chem; 2016 Oct; 291(43):22534-22543. PubMed ID: 27613865
    [TBL] [Abstract][Full Text] [Related]  

  • 59. SecA-Mediated Protein Translocation through the SecYEG Channel.
    Komarudin AG; Driessen AJM
    Microbiol Spectr; 2019 Jul; 7(4):. PubMed ID: 31373268
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria.
    Nikaido H; Pagès JM
    FEMS Microbiol Rev; 2012 Mar; 36(2):340-63. PubMed ID: 21707670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.